Arcturus Therapeutics Holdings Inc (ARCT) Stock Analysis

Arcturus Therapeutics Holdings Inc (ARCT) is a publicly traded company in the HEALTHCARE sector. It trades at $7.65, carries a market capitalization of $220.85M. This page summarizes the public market data, fundamentals, and frequently asked questions for ARCT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Arcturus Therapeutics Holdings Inc currently has a Bullish sentiment score of 0.42.

About Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics Holdings Inc. is a pioneering biopharmaceutical company based in San Diego, California, dedicated to the development of RNA-based therapeutics aimed at addressing critical unmet medical needs, particularly in liver and respiratory diseases. The company leverages its proprietary RNA delivery platform to advance a promising pipeline of innovative drug candidates, focusing on enhancing patient outcomes. With a strong emphasis on technological advancements and industry exper...

GNG Research Analysis

GNG Research scores Arcturus Therapeutics Holdings Inc (ARCT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ARCT.

Frequently Asked Questions

Does ARCT pay dividends?

Arcturus Therapeutics Holdings Inc (ARCT) does not currently pay a regular dividend.

What is ARCT's market cap?

Arcturus Therapeutics Holdings Inc (ARCT) has a market capitalization of $220.85M with a current stock price of $7.65.